This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries.
Andrew A. Nierenberg, MD
Advertisement
Articles by Andrew A. Nierenberg, MD
Advertisement
Latest Updated Articles
- The Introduction of Generic Risperidone in Medicare Part D
Published: January 20th 2016 | Updated:
- Current Perspectives on the Diagnosis and Treatment of Major Depressive Disorder
Published: September 1st 2001 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
4
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
5
